ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00956345
Recruitment Status : Completed
First Posted : August 11, 2009
Last Update Posted : January 20, 2017
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S